Brind.

ADC and Revvity are involved in accelerating the development of Antibody-Drug Conjugate (ADC) therapeutics.

1 report, 1 independent Updated Aug 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Revvity African Democratic Congress

Keep exploring

The entities involved

Revvity
American biotech company
- Revvity and Codexis, both healthcare companies, are currently competing against each other for market share.Sun 08:23
- Dovish remarks made on September 3, 2025, eased market concerns regarding high interest rates, involving the FED and Jerome Powell.Sun 01:44
African Democratic Congress
Nigerian Polictical Party
- The African Democratic Congress has alleged corruption in the operation of the Nigerian Education Loan Fund.Mon 16:29
- Kenneth Okonkwo, an ADC chieftain, made claims on Channels TV regarding his political status, referencing Anambra and Enugu States.Mon 15:57

Coverage

Newest first; wire copies grouped

Aug 6Business WireRevvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics Innovative plate-based internalization reagents designed to deliver accurate, high-th